Friday, December 17, 2021

A Concerned Look at Generex’s Board of Directors

›
Time sure has passed! It just took me 45 minutes to successfully log in to this account. This will be a short message. I'm basically try...
Wednesday, May 15, 2013

Antigen Express's AE37 Vaccine at ASCO 2013

›
Abstracts for the American Society of Clinical Oncology (ASCO) Annual Meeting were released today at 6 pm, ahead of the meeting which will ...
Monday, April 22, 2013

Two Abstracts Pertaining to the AE37 HER2/neu Vaccine Accepted as Poster Presentations at ASCO 2013

›
Two abstracts pertaining to Antigen Express' AE37 Her2/neu vaccine have been accepted for poster presentations at the 2013 American So...
Thursday, January 31, 2013

A Transcript of Dr. James Anderson's Comments During Today's Generex Conference Call

›
CEO Mark Fletcher: Last week, we announced that our partner in India, Shreya Life Sciences, has completed it’s phase three trial of General ...
Thursday, January 17, 2013

Emerging Vaccines Take Aim at Preventing Recurrent Breast Cancer

›
The following article was written by Joe Munch, and published in MD Anderson's OncoLog. OncoLog, January 2013, Vol. 58, No. 1 Myriad...
Tuesday, October 9, 2012

EASD 2012 Virtual Meeting, Buccal Spray Insulin in Subjects with Impaired Glucose Tolerance

›
Click HERE to view the virtual presentation for Oral-lyn treatment with IGT subjects given by Dr Andreea Soare from Italy's University ...
Wednesday, October 3, 2012

Army Surgeons Present New Research on Cancer Vaccine

›
The following press release was issued by the U.S. Army Medical Department on October 3rd, 2012: CHICAGO, Oct. 3, 2012 – Yesterday U.S. Ar...
Thursday, September 13, 2012

Generex's AE37 Vaccine Press Release Appears Off Target

›
I'm someone so clumsy that I'd be better off throwing an apple at an arrow, as opposed to an attempt at shooting an arrow at an appl...
Tuesday, September 11, 2012

Reasearchers from MD Anderson Present Interim Phase II Date for AE37 at ASCO's 2012 Breast Cancer Symposium

›
Early Efficacy Analysis of the AE37 Vaccine in Patients with HER2 Low-Expressing and Triple-Negative Breast Cancer . Abstract No: 109 ...
Sunday, July 22, 2012

Unusual Oral-lyn / IGT Data to be Presented at EASD 2012

›
The following abstract pertaing to an Oral-lyn study with subjects suffering fgrom impaired glucose tolerance will be presented at the 48th ...